Prediction of immunomodulatory drugs (IMiDs) sensitivity in myeloma via determination of baseline anti-oxidative stress capacity

MeSH terms

• Adult
• Aged
• Antineoplastic Agents / pharmacology*
• Antineoplastic Agents / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Antioxidants / pharmacology
• Bone Marrow Cells / drug effects
• Bone Marrow Cells / metabolism
• Bone Marrow Cells / pathology
• Drug Resistance, Neoplasm / drug effects*
• Female
• Humans
• Immunologic Factors / pharmacology*
• Immunologic Factors / therapeutic use
• Immunophenotyping
• Male
• Middle Aged
• Multiple Myeloma / diagnosis
• Multiple Myeloma / drug therapy
• Multiple Myeloma / immunology*
• Multiple Myeloma / metabolism*
• Oxidation-Reduction / drug effects
• Oxidative Stress / drug effects*
• Prognosis
• Treatment Outcome